BOS
CGEN icon

Bingham Osborn & Scarborough’s Compugen CGEN Stock Holding History

Bingham Osborn & Scarborough’s Portfolio CGEN Stock Details CGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-30,000
Closed -$115K – 136
2018
Q3 		$115K Hold
30,000
– – 0.01% 144
2018
Q2 		$99K Sell
30,000
-30,000
-50% -$113K 0.01% 140
2018
Q1 		$267K Buy
+60,000
New +$202K 0.03% 118

Other funds holding CGEN

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TFCM
Taylor Frigon Capital Management Scottsdale, Arizona $214M AUM 47.29% 1-Year Est. Return
RIL
Rothschild Investment LLC Chicago, Illinois $1.91B AUM 24.37% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
DC
Defender Capital Charlotte, North Carolina $308M AUM 4.52% 1-Year Est. Return
BFEC
Benjamin F. Edwards & Company St. Louis, Missouri $5.69B AUM 15.37% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
MAA
Matrix Asset Advisors White Plains, New York $1.23B AUM 26.4% 1-Year Est. Return

Bingham Osborn & Scarborough's CGEN Position: Q4 2018 in Review

Bingham Osborn & Scarborough sold out of Compugen (CGEN) in Q4 2018, closing a stake of 30,000 shares — an estimated $115K sold.

Bingham Osborn & Scarborough first reported a position in CGEN in Q1 2018 and held it in 3 quarters. The position peaked at $267K in Q1 2018. 39 funds tracked by Wall St. Rank hold CGEN as of Q4 2018.

  • Bingham Osborn & Scarborough reported no remaining Compugen position as of Q4 2018 after selling out during the quarter.
  • Bingham Osborn & Scarborough sold 30,000 Compugen shares in Q4 2018, an estimated $115K.
  • Bingham Osborn & Scarborough first reported a position in Compugen in Q1 2018 and held it in 3 quarters.
  • Bingham Osborn & Scarborough's Compugen position peaked at $267K in Q1 2018.
  • 39 funds tracked by Wall St. Rank held Compugen as of Q4 2018.

Based on Bingham Osborn & Scarborough's 13F filing for Q4 2018, filed 30 Jan 2019.